Dr. Emina Emilia Torlakovic obtained her M.D. at the University of Zagreb Medical School and her Ph.D. at the University of Oslo Medical School. She is board certified by The American Board of Pathology in Anatomic and Clinical Pathology with subspecialty boards in Hematopathology. She is an associate professor at the Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto and practices as a staff hematopathologist in the Department of Laboratory Hematology at the University Health Network. She was a founding member of the NordiQC and also co-founded CIQC, which she is currently co-directing. Dr. Torlakovic is the Chair of the National Standards Committee for High Complexity Testing of the Canadian Association of Pathologists. This committee prepared and published several Canadian guidelines for standardization of IHC testing. Dr. Torlakovic chairs the International Council for Standardization in Hematology Working Party for Standardization of Bone Marrow Immunohistochemistry, which developed international guidelines for bone marrow IHC. She was also a member of the ASCO/CAP expert panel that published guidelines for hormone receptor testing in breast cancer. She is also currently leading projects related to global standardization of controls in diagnostic IHC.
Dr. Torlakovic is also known for a discovery of a sessile serrated adenoma and her classification of serrated polyps of the colon is recently adopted for WHO classification.
Dr. Torlakovic has published over 80 peer reviewed manuscripts, authored a book on Bone Marrow Immunohistochemistry, and has lectured widely nationally and internationally on immunohistochemistry, quality assurance, and hematopathology.